SCHEMBL4014309

SCHEMBL4014309

CN(C)CCN1CCN(C(=O)O)CC1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.40
PARP2 Q9UGN5 1/20 0.40
P2RX7 Q99572 6/20 0.35
ALDH1A1 P00352 2/20 0.33
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
PTK2B Q14289 1/20 0.33
ESR2 Q92731 1/20 0.33
MAPK14 Q16539 2/20 0.33
SGK1 O00141 1/20 0.33
MAPK13 O15264 1/20 0.33
DAPK3 O43293 1/20 0.33
RIPK2 O43353 1/20 0.33
NTRK1 P04629 1/20 0.33
PRKCB P05771 1/20 0.33
LYN P07948 1/20 0.33
RET P07949 1/20 0.33
CYP3A4 P08684 1/20 0.33
BRAF P15056 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4012571 0.80 NR1H2 (0.39) PARP1PARP2ALDH1A1KDM4ELMNA
SCHEMBL16415209 0.78 ITGB3 (0.39) P2RX7ITGB3ITGA2BMCHR1
SCHEMBL20571751 0.78 P2RX7 (0.51) PARP1PARP2P2RX7ITGB3ITGA2B
SCHEMBL14447263 0.78 KDM4E (0.38) PARP1PARP2ALDH1A1KDM4ELMNA
SCHEMBL3179062 0.75 MCHR1 (0.43) PARP1ACHEMCHR1
SCHEMBL19439275 0.75 ITGB3 (0.38) PARP1PARP2P2RX7ITGB3ITGA2B
SCHEMBL2963862 0.75 P2RX7 (0.33) P2RX7ITGB3ITGA2BMCHR1
SCHEMBL23109052 0.75 KDM4E (0.36) PARP1PARP2ALDH1A1KDM4ELMNA
SCHEMBL2924196 0.74 P2RX7 (0.33) P2RX7ITGB3ITGA2BMCHR1
SCHEMBL25147579 0.73 PIK3CD (0.35) PARP1PARP2ALDH1A1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090306133-A1 New Acetyl Coenzyme A Carboxylase (ACC) Inhibitors And Uses In Treatments Of Obesity And Diabetes Mellitus - 087 ASTRAZENECA AB (SE) 2009-12-10 US disclosed
WO-2009082346-A1 NEW ACETYL COENZYME A CARBOXYLASE (ACC) INHIBITORS AND USES IN TREATMENTS OF OBESITY AND DIABETES MELLITUS - 087 ASTRAZENECA AB (SE) 2009-07-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090306133-A1 New Acetyl Coenzyme A Carboxylase (ACC) Inhibitors And Uses In Treatments Of Obesity And Diabetes Mellitus - 087 ACACA, ACACB, ACAT1 PARP1 1444/4885PARP2 2119/4885P2RX7 3989/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.